Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free NRXS Stock Alerts

NeurAxis (NRXS) Financials

NeurAxis logo
$6.78 -0.20 (-2.87%)
Closing price 07/16/2026 04:00 PM Eastern
Extended Trading
$6.55 -0.23 (-3.41%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for NeurAxis

Annual Income Statements for NeurAxis

This table shows NeurAxis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -4.78 -15 -8.45 -8.62
Consolidated Net Income / (Loss)		 -4.78 -15 -8.24 -7.80
Net Income / (Loss) Continuing Operations		 -4.78 -15 -8.24 -7.77
Total Pre-Tax Income 		-4.78 -15 -8.24 -7.80
Total Operating Income		 -3.37 -6.66 -7.16 -7.83
Total Gross Profit		 2.39 2.16 2.32 3.01
Total Revenue		 2.68 2.46 2.69 3.57
Operating Revenue		 2.68 2.46 2.69 3.57
Total Cost of Revenue		 0.30 0.30 0.36 0.56
Operating Cost of Revenue		 0.30 0.30 0.36 0.56
Total Operating Expenses		 5.76 8.82 9.48 11
Selling, General & Admin Expense		 5.53 8.65 9.05 10
Research & Development Expense		 0.23 0.17 0.43 0.49
Total Other Income / (Expense), net		 -1.41 -7.96 -1.08 0.03
Interest Expense		 0.42 9.01 0.30 0.07
Other Income / (Expense), net		 -0.99 1.05 -0.78 0.10
Other Gains / (Losses), net		 - - - 0.03
Preferred Stock Dividends Declared		 - 0.00 0.21 0.81
Basic Earnings per Share		 ($2.77) ($4.50) ($1.22) ($0.95)
Weighted Average Basic Shares Outstanding		 2.00M 3.25M 6.92M 9.08M
Diluted Earnings per Share		 ($2.77) ($4.50) ($1.22) ($0.95)
Weighted Average Diluted Shares Outstanding		 2.00M 3.25M 6.92M 9.08M
Weighted Average Basic & Diluted Shares Outstanding		 - - 7.22M 11.19M

Quarterly Income Statements for NeurAxis

This table shows NeurAxis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -8.63 -1.59 -2.12 -2.92 -1.80 -1.61 -2.49 -1.90 -2.32 -1.90 -1.95
Consolidated Net Income / (Loss)		 -8.63 -1.59 -2.12 -2.92 -1.76 -1.45 -2.28 -1.69 -2.12 -1.71 -1.76
Net Income / (Loss) Continuing Operations		 -8.63 -1.59 -2.12 -2.92 -1.76 -1.45 -2.26 -1.69 -2.12 -1.70 -1.76
Total Pre-Tax Income 		-8.63 -1.59 -2.12 -2.92 -1.76 -1.45 -2.28 -1.69 -2.12 -1.71 -1.76
Total Operating Income		 -3.02 -1.63 -1.83 -2.21 -1.65 -1.47 -2.30 -1.72 -2.10 -1.72 -1.74
Total Gross Profit		 0.41 0.46 0.57 0.54 0.57 0.64 0.76 0.75 0.68 0.83 1.39
Total Revenue		 0.48 0.53 0.65 0.61 0.67 0.76 0.90 0.89 0.81 0.97 1.61
Operating Revenue		 0.48 0.53 0.65 0.61 0.67 0.76 0.90 0.89 0.81 0.97 1.61
Total Cost of Revenue		 0.07 0.07 0.08 0.07 0.10 0.12 0.14 0.15 0.14 0.14 0.22
Operating Cost of Revenue		 0.07 0.07 0.08 0.07 0.10 0.12 0.14 0.15 0.14 0.14 0.22
Total Operating Expenses		 3.43 2.09 2.40 2.74 2.22 2.11 3.05 2.47 2.78 2.54 3.13
Selling, General & Admin Expense		 3.39 2.09 2.40 2.69 2.09 1.86 2.93 2.41 2.65 2.30 3.03
Research & Development Expense		 0.04 -0.00 0.01 0.05 0.13 0.25 0.12 0.06 0.13 0.24 0.10
Total Other Income / (Expense), net		 -5.60 0.04 -0.29 -0.71 -0.10 0.02 0.02 0.03 -0.02 0.01 -0.02
Interest Expense		 6.21 0.02 0.05 0.14 0.11 0.00 0.00 0.01 0.03 0.03 0.03
Other Income / (Expense), net		 0.61 0.06 -0.24 -0.57 0.00 0.02 0.02 0.04 0.01 0.04 0.01
Preferred Stock Dividends Declared		 - - 0.00 0.00 0.04 0.17 0.21 0.21 0.20 0.19 0.19
Basic Earnings per Share		 ($2.38) $0.27 ($0.32) ($0.42) ($0.25) ($0.23) ($0.33) ($0.22) ($0.24) ($0.16) ($0.18)
Weighted Average Basic Shares Outstanding		 3.63M 3.25M 6.55M 6.92M 7.17M 6.92M 7.46M 8.52M 9.88M 9.08M 10.95M
Diluted Earnings per Share		 ($2.38) $0.27 ($0.32) ($0.42) ($0.25) ($0.23) ($0.33) ($0.22) ($0.24) ($0.16) ($0.18)
Weighted Average Diluted Shares Outstanding		 3.63M 3.25M 6.55M 6.92M 7.17M 6.92M 7.46M 8.52M 9.88M 9.08M 10.95M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 6.65M 6.84M 6.98M 7.22M 7.22M 9.86M 10.65M 11.19M 12.38M

Annual Cash Flow Statements for NeurAxis

This table details how cash moves in and out of NeurAxis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -0.07 -0.18 3.62 1.27
Net Cash From Operating Activities		 -2.30 -6.69 -6.10 -6.43
Net Cash From Continuing Operating Activities		 -2.30 -6.69 -6.10 -6.43
Net Income / (Loss) Continuing Operations		 -4.78 -15 -8.24 -7.80
Consolidated Net Income / (Loss)		 -4.78 -15 -8.24 -7.80
Depreciation Expense		 0.04 0.04 0.04 0.06
Amortization Expense		 0.10 4.88 0.13 0.00
Non-Cash Adjustments To Reconcile Net Income		 1.07 3.69 1.80 0.69
Changes in Operating Assets and Liabilities, net		 1.28 -0.68 0.18 0.61
Net Cash From Investing Activities		 -0.06 -0.07 -0.03 -0.13
Net Cash From Continuing Investing Activities		 -0.06 -0.07 -0.03 -0.13
Purchase of Property, Plant & Equipment		 -0.00 -0.03 -0.03 -0.03
Acquisitions		 -0.06 -0.04 0.00 -0.10
Net Cash From Financing Activities		 2.29 6.59 9.74 7.83
Net Cash From Continuing Financing Activities		 2.29 6.57 9.74 7.83
Repayment of Debt		 -0.29 -4.11 -0.47 -0.28
Issuance of Debt		 3.32 5.62 4.94 0.00
Issuance of Preferred Equity		 - 0.00 5.25 0.00
Issuance of Common Equity		 0.00 5.06 0.00 7.73
Other Financing Activities, net		 -0.74 0.00 0.03 0.39
Cash Interest Paid		 0.20 0.21 0.03 0.01
Cash Income Taxes Paid		 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for NeurAxis

This table details how cash moves in and out of NeurAxis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 0.71 -0.68 0.00 1.68 -1.50 3.44 -1.69 3.98 -1.61 0.59 2.11
Net Cash From Operating Activities		 -2.82 -2.63 -1.33 -1.62 -1.39 -1.76 -1.60 -1.47 -1.43 -1.93 -1.23
Net Cash From Continuing Operating Activities		 -2.82 -2.63 -1.33 -1.62 -1.39 -1.76 -1.60 -1.47 -1.43 -1.93 -1.23
Net Income / (Loss) Continuing Operations		 -8.63 -1.59 -2.12 -2.92 -1.76 -1.45 -2.28 -1.69 -2.12 -1.71 -1.76
Consolidated Net Income / (Loss)		 -8.63 -1.59 -2.12 -2.92 -1.76 -1.45 -2.28 -1.69 -2.12 -1.71 -1.76
Depreciation Expense		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02
Non-Cash Adjustments To Reconcile Net Income		 7.03 -1.82 0.34 0.84 0.58 0.04 0.11 0.16 0.22 0.18 0.42
Changes in Operating Assets and Liabilities, net		 -2.56 0.77 0.41 0.39 -0.27 -0.35 0.56 0.05 0.46 -0.43 0.09
Net Cash From Investing Activities		 -0.04 -0.02 -0.01 -0.01 -0.00 - -0.02 -0.01 - -0.11 0.00
Net Cash From Continuing Investing Activities		 -0.04 -0.02 -0.01 -0.01 -0.00 - -0.02 -0.01 - -0.11 0.00
Purchase of Property, Plant & Equipment		 -0.00 -0.02 -0.01 -0.01 -0.00 - -0.02 -0.01 - -0.01 0.00
Net Cash From Financing Activities		 3.57 1.96 1.35 3.31 -0.11 5.19 -0.07 5.46 -0.18 2.63 3.34
Net Cash From Continuing Financing Activities		 3.57 1.94 1.35 3.31 -0.11 5.19 -0.07 5.46 -0.18 2.63 3.34
Repayment of Debt		 -0.76 -0.62 -0.05 -0.06 -0.11 -0.25 -0.07 -0.09 -0.07 -0.06 -0.06
Repurchase of Common Equity		 - - - - - - 0.00 - -0.11 - -0.09
Issuance of Common Equity		 5.46 -0.41 0.03 - - -0.03 0.00 6.00 - 1.73 2.99
Other Financing Activities, net		 - 2.42 - - - - 0.00 - - - 0.50
Cash Interest Paid		 0.13 0.02 0.02 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Cash Income Taxes Paid		 - - 0.00 - - - 0.00 0.01 0.00 -0.01 0.00

Annual Balance Sheets for NeurAxis

This table presents NeurAxis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1.48 0.51 4.76 6.40
Total Current Assets		 0.48 0.24 4.27 5.73
Cash & Equivalents		 0.25 0.08 3.70 4.97
Accounts Receivable		 0.17 0.07 0.24 0.20
Inventories, net		 0.05 0.02 0.04 0.26
Prepaid Expenses		 0.00 0.07 0.28 0.32
Plant, Property, & Equipment, net		 0.09 0.09 0.09 0.08
Plant, Property & Equipment, gross		 0.41 0.44 0.46 0.38
Accumulated Depreciation		 0.32 0.35 0.37 0.31
Total Noncurrent Assets		 0.92 0.18 0.40 0.60
Intangible Assets		 0.08 0.11 0.10 0.27
Other Noncurrent Operating Assets		 0.84 0.07 0.30 0.32
Total Liabilities & Shareholders' Equity		 1.48 0.51 4.76 6.40
Total Liabilities		 7.05 1.91 2.69 3.00
Total Current Liabilities		 6.98 1.89 2.43 2.79
Short-Term Debt		 0.49 0.15 0.15 0.15
Accounts Payable		 1.59 1.20 0.60 0.14
Accrued Expenses		 0.83 0.40 1.58 2.39
Customer Deposits		 0.06 0.07 0.03 0.03
Other Current Liabilities		 4.00 0.06 0.07 0.08
Total Noncurrent Liabilities		 0.08 0.03 0.26 0.21
Other Noncurrent Operating Liabilities		 0.08 0.03 0.26 0.21
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -5.57 -1.40 2.07 3.40
Total Preferred & Common Equity		 -5.57 -1.40 2.07 3.40
Preferred Stock		 0.00 0.00 0.00 0.00
Total Common Equity		 -5.57 -1.40 2.06 3.40
Common Stock		 28 47 59 68
Retained Earnings		 -34 -49 -57 -65

Quarterly Balance Sheets for NeurAxis

This table presents NeurAxis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 0.95 2.63 1.14 3.03 7.09 5.78 8.75
Total Current Assets		 0.41 2.11 0.63 2.54 6.62 4.99 8.14
Cash & Equivalents		 0.08 1.77 0.26 2.01 5.99 4.38 7.08
Accounts Receivable		 0.09 0.15 0.05 0.24 0.13 0.11 0.39
Inventories, net		 0.02 0.04 0.02 0.04 0.13 0.11 0.24
Prepaid Expenses		 0.22 0.16 0.30 0.25 0.37 0.39 0.44
Plant, Property, & Equipment, net		 0.10 0.10 0.09 0.10 0.10 0.09 0.07
Plant, Property & Equipment, gross		 0.45 0.46 0.46 0.48 0.48 0.38 0.38
Accumulated Depreciation		 0.36 0.36 0.37 0.38 0.38 0.29 0.31
Total Noncurrent Assets		 0.44 0.43 0.42 0.39 0.37 0.70 0.54
Intangible Assets		 0.11 0.10 0.10 0.09 0.09 0.28 0.27
Other Noncurrent Operating Assets		 0.34 0.32 0.32 0.29 0.28 0.42 0.27
Total Liabilities & Shareholders' Equity		 0.95 2.63 1.14 3.03 7.09 5.78 8.75
Total Liabilities		 4.13 7.89 2.94 2.77 2.83 3.49 3.00
Total Current Liabilities		 3.82 7.59 2.66 2.10 2.35 3.15 2.81
Short-Term Debt		 1.40 4.77 0.15 0.15 0.19 0.20 0.17
Accounts Payable		 1.24 1.12 0.96 0.54 0.46 0.89 0.31
Accrued Expenses		 0.82 1.31 1.17 1.37 1.65 1.96 2.26
Customer Deposits		 0.09 0.08 0.08 0.04 0.03 0.04 0.03
Other Current Liabilities		 0.28 0.32 0.30 0.01 0.01 0.07 0.05
Total Noncurrent Liabilities		 0.31 0.30 0.27 0.67 0.49 0.34 0.18
Other Noncurrent Operating Liabilities		 0.31 0.30 0.27 0.67 0.49 0.34 0.18
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -3.18 -5.26 -1.79 0.26 4.25 2.28 5.75
Total Preferred & Common Equity		 -3.18 -5.26 -1.79 0.26 4.25 2.28 5.75
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -3.18 -5.26 -1.80 0.25 4.25 2.28 5.74
Common Stock		 47 48 54 59 65 65 72
Retained Earnings		 -51 -54 -55 -59 -61 -63 -66

Annual Metrics And Ratios for NeurAxis

This table displays calculated financial ratios and metrics derived from NeurAxis' official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 6,980,227.00 10,652,812.00
DEI Adjusted Shares Outstanding		 0.00 0.00 6,980,227.00 10,652,812.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -1.21 -0.81
Growth Metrics		 - - - -
Revenue Growth		 0.00% -8.37% 9.18% 32.89%
EBITDA Growth		 0.00% 83.51% -1,016.14% 1.41%
EBIT Growth		 0.00% -28.81% -41.32% 2.70%
NOPAT Growth		 0.00% -97.63% -7.39% -9.40%
Net Income Growth		 0.00% -205.99% 43.65% 5.35%
EPS Growth		 0.00% -62.45% 72.89% 22.13%
Operating Cash Flow Growth		 0.00% -191.30% 8.90% -5.49%
Free Cash Flow Firm Growth		 0.00% 0.00% 43.84% -13.76%
Invested Capital Growth		 0.00% 75.01% -10.59% 3.90%
Revenue Q/Q Growth		 0.00% 0.00% 9.35% 6.16%
EBITDA Q/Q Growth		 0.00% 0.00% 1.57% -2.92%
EBIT Q/Q Growth		 0.00% 0.00% 1.58% -3.13%
NOPAT Q/Q Growth		 0.00% 0.00% 2.21% -3.30%
Net Income Q/Q Growth		 0.00% 0.00% 1.72% -3.46%
EPS Q/Q Growth		 0.00% 0.00% -69.44% 6.86%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 12.50% -2.81%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -4.18%
Invested Capital Q/Q Growth		 0.00% 0.00% 22.66% 25.26%
Profitability Metrics		 - - - -
Gross Margin		 88.94% 87.67% 86.52% 84.23%
EBITDA Margin		 -157.42% -28.32% -289.53% -214.81%
Operating Margin		 -125.61% -270.91% -266.46% -219.37%
EBIT Margin		 -162.49% -228.41% -295.64% -216.47%
Profit (Net Income) Margin		 -178.05% -594.57% -306.84% -218.55%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 109.57% 260.30% 103.79% 100.96%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 85.76% 419.29% -2,480.49% -285.36%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -294.63% -564.69% -301.53% -138.45%
Return on Assets (ROA)		 -322.84% -1,469.91% -312.94% -139.77%
Return on Common Equity (ROCE)		 85.77% 419.33% -2,464.51% -284.94%
Return on Equity Simple (ROE_SIMPLE)		 85.76% 1,042.35% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.36 -4.67 -5.01 -5.48
NOPAT Margin		 -87.93% -189.64% -186.52% -153.56%
Net Nonoperating Expense Percent (NNEP)		 1,027.26% 6,531.51% -186.09% -55.50%
Return On Investment Capital (ROIC_SIMPLE)		 - 371.67% -225.47% -154.49%
Cost of Revenue to Revenue		 11.06% 12.33% 13.48% 15.77%
SG&A Expenses to Revenue		 206.14% 351.70% 336.83% 289.77%
R&D to Revenue		 8.40% 6.88% 16.14% 13.83%
Operating Expenses to Revenue		 214.54% 358.58% 352.98% 303.60%
Earnings before Interest and Taxes (EBIT)		 -4.36 -5.62 -7.94 -7.73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.23 -0.70 -7.78 -7.67
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 7.95 14.24
Price to Tangible Book Value (P/TBV)		 0.00 0.00 8.34 15.50
Price to Revenue (P/Rev)		 2.46 0.00 6.11 13.55
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.54 0.00 4.79 12.20
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 -0.09 -0.11 0.07 0.04
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 -0.04 -0.04 -5.23 -1.53
Leverage Ratio		 -0.27 -0.29 7.93 2.04
Compound Leverage Factor		 -0.29 -0.74 8.23 2.06
Debt to Total Capital		 -9.62% -11.80% 6.94% 4.18%
Short-Term Debt to Total Capital		 -9.62% -11.80% 6.94% 4.18%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 -0.01% 0.00% 0.19% 0.11%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 109.63% 111.80% 92.87% 95.71%
Debt to EBITDA		 -0.12 -0.21 -0.02 -0.02
Net Debt to EBITDA		 -0.06 -0.10 0.46 0.63
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.21 -0.03 -0.03 -0.03
Net Debt to NOPAT		 -0.10 -0.01 0.71 0.88
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 -44.70 0.00 -17.54 -7.34
Noncontrolling Interest Sharing Ratio		 -0.01% -0.01% 0.64% 0.15%
Liquidity Ratios		 - - - -
Current Ratio		 0.07 0.13 1.75 2.05
Quick Ratio		 0.06 0.08 1.62 1.85
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -8.67 -4.87 -5.54
Operating Cash Flow to CapEx		 -165,324.03% -21,747.11% -21,955.16% -20,651.18%
Free Cash Flow to Firm to Interest Expense		 0.00 -0.96 -16.19 -74.88
Operating Cash Flow to Interest Expense		 -5.50 -0.74 -20.28 -86.97
Operating Cash Flow Less CapEx to Interest Expense		 -5.51 -0.75 -20.37 -87.39
Efficiency Ratios		 - - - -
Asset Turnover		 1.81 2.47 1.02 0.64
Accounts Receivable Turnover		 15.39 19.87 16.90 16.21
Inventory Turnover		 6.17 8.75 11.05 3.73
Fixed Asset Turnover		 30.50 27.87 30.09 43.12
Accounts Payable Turnover		 0.19 0.22 0.40 1.53
Days Sales Outstanding (DSO)		 23.71 18.37 21.59 22.51
Days Inventory Outstanding (DIO)		 59.14 41.72 33.05 97.73
Days Payable Outstanding (DPO)		 1,956.25 1,682.35 908.04 238.72
Cash Conversion Cycle (CCC)		 -1,873.39 -1,622.26 -853.40 -118.47
Capital & Investment Metrics		 - - - -
Invested Capital		 -5.34 -1.33 -1.47 -1.42
Invested Capital Turnover		 -0.50 -0.74 -1.91 -2.47
Increase / (Decrease) in Invested Capital		 0.00 4.00 -0.14 0.06
Enterprise Value (EV)		 6.83 0.00 13 44
Market Capitalization		 6.59 0.00 16 48
Book Value per Share		 ($2.78) ($0.43) $0.30 $0.32
Tangible Book Value per Share		 ($2.82) ($0.46) $0.28 $0.29
Total Capital		 -5.08 -1.26 2.22 3.55
Total Debt		 0.49 0.15 0.15 0.15
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 0.24 0.07 -3.54 -4.82
Capital Expenditures (CapEx)		 0.00 0.03 0.03 0.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -6.27 -1.57 -1.71 -1.88
Debt-free Net Working Capital (DFNWC)		 -6.01 -1.49 1.99 3.09
Net Working Capital (NWC)		 -6.50 -1.64 1.83 2.94
Net Nonoperating Expense (NNE)		 2.42 9.96 3.23 2.32
Net Nonoperating Obligations (NNO)		 0.24 0.07 -3.54 -4.82
Total Depreciation and Amortization (D&A)		 0.14 4.92 0.16 0.06
Debt-free, Cash-free Net Working Capital to Revenue		 -233.38% -63.96% -63.66% -52.55%
Debt-free Net Working Capital to Revenue		 -223.93% -60.77% 73.98% 86.55%
Net Working Capital to Revenue		 -242.15% -66.79% 68.24% 82.40%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 ($4.50) ($1.22) ($0.95)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 3.25M 6.92M 9.08M
Adjusted Diluted Earnings per Share		 $0.00 ($4.50) ($1.22) ($0.95)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 3.25M 6.92M 9.08M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 7.22M 11.19M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.36 -4.67 -5.01 -5.48
Normalized NOPAT Margin		 -87.93% -189.64% -186.52% -153.56%
Pre Tax Income Margin		 -178.05% -594.57% -306.84% -218.55%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 -10.45 -0.62 -26.41 -104.46
NOPAT to Interest Expense		 -5.65 -0.52 -16.66 -74.10
EBIT Less CapEx to Interest Expense		 -10.45 -0.63 -26.50 -104.88
NOPAT Less CapEx to Interest Expense		 -5.66 -0.52 -16.75 -74.52
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for NeurAxis

This table displays calculated financial ratios and metrics derived from NeurAxis' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 0.00 0.00 0.00 6,647,960.00 6,980,227.00 6,980,227.00 7,215,864.00 9,858,716.00 9,858,716.00 10,652,812.00 11,187,639.00
DEI Adjusted Shares Outstanding		 0.00 0.00 0.00 6,647,960.00 6,980,227.00 6,980,227.00 7,215,864.00 9,858,716.00 9,858,716.00 10,652,812.00 11,187,639.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 0.00 -0.44 -0.26 -0.23 -0.35 -0.19 -0.24 -0.18 -0.17
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% -19.68% -5.34% 39.62% 43.22% 38.51% 46.21% 21.72% 27.19% 79.52%
EBITDA Growth		 0.00% 0.00% -192.98% -958.87% -49.00% 7.92% -11.28% 38.33% -29.85% -15.10% 24.28%
EBIT Growth		 0.00% 0.00% -333.05% -140.52% 31.68% 8.09% -9.85% 39.53% -26.88% -16.22% 23.77%
NOPAT Growth		 0.00% 0.00% -104.42% -97.47% 45.36% 9.93% -25.27% 22.16% -27.18% -17.07% 24.16%
Net Income Growth		 0.00% 0.00% 2.43% -30.51% 79.65% 9.07% -7.45% 42.06% -20.94% -18.01% 22.70%
EPS Growth		 0.00% 0.00% 72.88% 65.29% 89.50% -185.19% -3.13% 47.62% 4.00% 30.43% 45.45%
Operating Cash Flow Growth		 0.00% 0.00% -113.86% -158.33% 50.54% 33.14% -20.38% 9.14% -2.49% -10.01% 23.32%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -419.96% -369.03% -297.10% -42.24% 12.04%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -10.59% 14.62% 31.55% 0.56% 3.90% 27.25%
Revenue Q/Q Growth		 -26.09% 11.31% 21.67% -5.43% 9.01% 14.18% 17.67% -0.18% -9.25% 19.31% 66.08%
EBITDA Q/Q Growth		 -321.24% -45.54% -30.57% -32.28% 40.72% 10.06% -57.79% 26.69% -24.81% 20.27% -3.80%
EBIT Q/Q Growth		 -109.43% 34.87% -31.77% -33.82% 40.51% 12.38% -57.48% 26.33% -24.82% 19.74% -3.29%
NOPAT Q/Q Growth		 -170.45% 46.12% -12.51% -20.45% 25.17% 11.18% -56.49% 25.15% -22.25% 18.25% -1.39%
Net Income Q/Q Growth		 -285.82% 81.54% -33.18% -37.59% 39.84% 17.51% -57.38% 25.82% -25.58% 19.51% -3.09%
EPS Q/Q Growth		 -96.69% 111.34% -218.52% -31.25% 40.48% 8.00% -43.48% 33.33% -9.09% 33.33% -12.50%
Operating Cash Flow Q/Q Growth		 -350.44% 6.63% 49.34% -21.24% 13.77% -26.23% 8.79% 8.49% 2.72% -35.49% 36.42%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 21.10% 5.58% -217.86% -112.33% -1.83% 22.65% 14.95% -31.30%
Invested Capital Q/Q Growth		 0.00% 0.00% -40.21% -20.66% 15.48% 22.66% -8.25% 3.26% -22.79% 25.26% 18.05%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 85.91% 86.39% 88.39% 87.99% 85.44% 84.71% 84.43% 83.60% 83.30% 85.40% 86.42%
EBITDA Margin		 -224.83% -293.98% -315.48% -441.28% -239.94% -189.01% -253.46% -186.12% -255.96% -171.05% -106.91%
Operating Margin		 -633.00% -306.39% -283.33% -360.89% -247.71% -192.68% -256.25% -192.14% -258.82% -177.34% -108.26%
EBIT Margin		 -505.75% -295.94% -320.49% -453.51% -247.47% -189.91% -254.17% -187.56% -257.96% -173.53% -107.92%
Profit (Net Income) Margin		 -1,806.51% -299.61% -327.95% -477.14% -263.30% -190.22% -254.42% -189.07% -261.62% -176.49% -109.55%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 357.20% 101.24% 102.33% 105.21% 106.40% 100.17% 100.10% 100.80% 101.42% 101.70% 101.51%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 419.29% 457.66% 580.26% 934.92% -2,480.49% 574.14% 1,427.19% -3,071.15% -285.36% -242.53%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% -731.63% -779.96% -780.85% -1,063.32% -193.69% -375.28% -124.16% -250.69% -110.99% -78.48%
Return on Assets (ROA)		 0.00% -740.70% -798.12% -821.54% -1,131.36% -194.01% -375.64% -125.15% -254.24% -112.88% -79.66%
Return on Common Equity (ROCE)		 0.00% 419.33% 457.66% 580.26% 936.00% -2,464.51% 574.98% 1,432.72% -3,033.80% -284.94% -242.21%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 457.66% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.12 -1.14 -1.28 -1.54 -1.16 -1.03 -1.61 -1.20 -1.47 -1.20 -1.22
NOPAT Margin		 -443.10% -214.47% -198.33% -252.62% -173.39% -134.87% -179.37% -134.50% -181.17% -124.14% -75.78%
Net Nonoperating Expense Percent (NNEP)		 0.00% 651.00% 127.53% 91.47% -1,058.94% -24.26% -248.59% -34.90% -30.40% -12.13% -12.39%
Return On Investment Capital (ROIC_SIMPLE)		 - 90.81% 71.72% 314.59% 70.21% -46.20% -393.11% -27.06% -59.26% -33.88% -20.59%
Cost of Revenue to Revenue		 14.09% 13.61% 11.61% 12.01% 14.56% 15.29% 15.57% 16.40% 16.70% 14.60% 13.58%
SG&A Expenses to Revenue		 709.50% 393.20% 370.86% 439.99% 314.21% 244.87% 327.52% 269.21% 325.99% 237.55% 188.49%
R&D to Revenue		 9.41% -0.42% 0.86% 8.88% 18.94% 32.51% 13.16% 6.52% 16.13% 25.19% 6.19%
Operating Expenses to Revenue		 718.91% 392.78% 371.72% 448.88% 333.15% 277.38% 340.68% 275.73% 342.12% 262.74% 194.68%
Earnings before Interest and Taxes (EBIT)		 -2.41 -1.57 -2.07 -2.77 -1.65 -1.45 -2.28 -1.68 -2.09 -1.68 -1.74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.07 -1.56 -2.04 -2.70 -1.60 -1.44 -2.27 -1.66 -2.08 -1.66 -1.72
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 7.95 61.03 4.11 13.31 14.24 14.41
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 8.34 96.82 4.20 15.20 15.50 15.12
Price to Revenue (P/Rev)		 0.00 0.00 0.00 8.15 8.30 6.11 5.29 5.43 9.03 13.55 19.34
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 9.48 8.26 4.79 4.66 3.63 7.79 12.20 17.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 -0.11 -0.44 -0.91 -0.08 0.07 0.58 0.04 0.09 0.04 0.03
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -0.05 -0.41 -0.57 0.06 -5.23 0.18 2.78 -8.75 -1.53 -1.46
Leverage Ratio		 0.00 -0.29 -0.30 -0.50 -0.64 7.93 -1.36 -9.67 14.09 2.04 1.96
Compound Leverage Factor		 0.00 -0.29 -0.30 -0.53 -0.68 7.94 -1.36 -9.75 14.29 2.08 1.99
Debt to Total Capital		 0.00% -11.80% -78.07% -970.85% -8.97% 6.94% 36.75% 4.29% 7.89% 4.18% 2.87%
Short-Term Debt to Total Capital		 0.00% -11.80% -78.07% -970.85% -8.97% 6.94% 36.75% 4.29% 7.89% 4.18% 2.87%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% -0.13% 0.19% 1.05% 0.09% 0.16% 0.11% 0.06%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 111.80% 178.07% 1,070.85% 109.10% 92.87% 62.20% 95.62% 91.96% 95.71% 97.07%
Debt to EBITDA		 0.00 -0.21 -0.28 -0.65 -0.02 -0.02 -0.02 -0.03 -0.03 -0.02 -0.02
Net Debt to EBITDA		 0.00 -0.10 -0.27 -0.41 0.01 0.46 0.23 0.83 0.56 0.63 0.97
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 -0.03 -0.26 -0.78 -0.03 -0.03 -0.03 -0.04 -0.04 -0.03 -0.03
Net Debt to NOPAT		 0.00 -0.01 -0.25 -0.49 0.02 0.71 0.35 1.16 0.79 0.88 1.36
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 -32.20 -68.36 -13.03 -25.28 -7.91 -10.26 -4.22 6.51
Noncontrolling Interest Sharing Ratio		 0.00% -0.01% 0.00% 0.00% -0.12% 0.64% -0.15% -0.39% 1.22% 0.15% 0.13%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 0.13 0.11 0.28 0.24 1.75 1.21 2.82 1.58 2.05 2.89
Quick Ratio		 0.00 0.08 0.05 0.25 0.12 1.62 1.07 2.61 1.43 1.85 2.65
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.59 0.71 0.75 -0.89 -1.88 -1.91 -1.48 -1.26 -1.65
Operating Cash Flow to CapEx		 -105,320.94% -16,393.76% -9,048.77% -18,594.69% -31,886.49% 0.00% -8,909.19% -20,135.70% 0.00% -32,994.87% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 12.18 4.92 7.12 -369.83 -840.37 -142.49 -49.92 -43.98 -63.14
Operating Cash Flow to Interest Expense		 -0.45 -151.13 -27.61 -11.18 -13.19 -734.41 -716.88 -109.24 -48.13 -67.54 -46.96
Operating Cash Flow Less CapEx to Interest Expense		 -0.45 -152.05 -27.92 -11.24 -13.24 -734.41 -724.92 -109.78 -48.13 -67.75 -46.96
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 2.47 2.43 1.72 4.30 1.02 1.48 0.66 0.97 0.64 0.73
Accounts Receivable Turnover		 0.00 19.87 25.42 0.00 0.00 16.90 17.56 23.35 41.74 16.21 13.62
Inventory Turnover		 0.00 8.75 13.99 0.00 0.00 11.05 14.80 5.74 8.11 3.73 4.66
Fixed Asset Turnover		 0.00 27.87 24.19 0.00 0.00 30.09 29.52 32.73 37.42 43.12 50.00
Accounts Payable Turnover		 0.00 0.22 0.23 0.00 0.00 0.40 0.48 0.63 0.58 1.53 1.53
Days Sales Outstanding (DSO)		 0.00 18.37 14.36 0.00 0.00 21.59 20.78 15.64 8.74 22.51 26.80
Days Inventory Outstanding (DIO)		 0.00 41.72 26.09 0.00 0.00 33.05 24.66 63.62 45.02 97.73 78.40
Days Payable Outstanding (DPO)		 0.00 1,682.35 1,598.15 0.00 0.00 908.04 758.45 578.22 627.03 238.72 238.95
Cash Conversion Cycle (CCC)		 0.00 -1,622.26 -1,557.71 0.00 0.00 -853.40 -713.01 -498.97 -573.27 -118.47 -133.75
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 -1.33 -1.87 -2.26 -1.91 -1.47 -1.60 -1.54 -1.90 -1.42 -1.16
Invested Capital Turnover		 0.00 -1.84 -2.46 -2.01 -2.58 -1.91 -1.69 -1.69 -1.77 -2.47 -3.10
Increase / (Decrease) in Invested Capital		 0.00 0.00 -1.87 -2.26 -1.91 -0.14 0.27 0.71 0.01 0.06 0.44
Enterprise Value (EV)		 0.00 0.00 0.00 21 20 13 14 12 26 44 76
Market Capitalization		 0.00 0.00 0.00 18 20 16 16 17 30 48 83
Book Value per Share		 $0.00 ($0.43) ($0.49) ($0.79) ($0.26) $0.30 $0.04 $0.59 $0.23 $0.32 $0.51
Tangible Book Value per Share		 $0.00 ($0.46) ($0.50) ($0.81) ($0.28) $0.28 $0.02 $0.58 $0.20 $0.29 $0.49
Total Capital		 0.00 -1.26 -1.79 -0.49 -1.65 2.22 0.41 4.44 2.48 3.55 5.92
Total Debt		 0.00 0.15 1.40 4.77 0.15 0.15 0.15 0.19 0.20 0.15 0.17
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 0.07 1.31 3.00 -0.11 -3.54 -1.86 -5.80 -4.18 -4.82 -6.91
Capital Expenditures (CapEx)		 0.00 0.02 0.01 0.01 0.00 0.00 0.02 0.01 0.00 0.01 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -1.57 -2.09 -2.48 -2.15 -1.71 -1.42 -1.53 -2.34 -1.88 -1.58
Debt-free Net Working Capital (DFNWC)		 0.00 -1.49 -2.01 -0.71 -1.88 1.99 0.59 4.46 2.04 3.09 5.50
Net Working Capital (NWC)		 0.00 -1.64 -3.41 -5.48 -2.03 1.83 0.44 4.27 1.84 2.94 5.33
Net Nonoperating Expense (NNE)		 6.51 0.45 0.84 1.37 0.60 0.42 0.67 0.49 0.65 0.51 0.54
Net Nonoperating Obligations (NNO)		 0.00 0.07 1.31 3.00 -0.11 -3.54 -1.86 -5.80 -4.18 -4.82 -6.91
Total Depreciation and Amortization (D&A)		 1.34 0.01 0.03 0.07 0.05 0.01 0.01 0.01 0.02 0.02 0.02
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -63.96% -90.96% -109.40% -87.35% -63.66% -48.22% -47.44% -69.62% -52.55% -36.91%
Debt-free Net Working Capital to Revenue		 0.00% -60.77% -87.41% -31.54% -76.73% 73.98% 20.10% 138.68% 60.56% 86.55% 128.42%
Net Working Capital to Revenue		 0.00% -66.79% -148.07% -241.83% -82.74% 68.24% 14.99% 132.76% 54.74% 82.40% 124.46%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.27 ($0.32) ($0.42) ($0.25) ($0.23) ($0.33) ($0.22) ($0.24) ($0.16) ($0.18)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 3.25M 6.55M 6.92M 7.17M 6.92M 7.46M 8.52M 9.88M 9.08M 10.95M
Adjusted Diluted Earnings per Share		 $0.00 $0.27 ($0.32) ($0.42) ($0.25) ($0.23) ($0.33) ($0.22) ($0.24) ($0.16) ($0.18)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 3.25M 6.55M 6.92M 7.17M 6.92M 7.46M 8.52M 9.88M 9.08M 10.95M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 6.65M 6.84M 6.98M 7.22M 7.22M 9.86M 10.65M 11.19M 12.38M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.12 -1.14 -1.28 -1.54 -1.16 -1.03 -1.61 -1.20 -1.47 -1.20 -1.22
Normalized NOPAT Margin		 -443.10% -214.47% -198.33% -252.62% -173.39% -134.87% -179.37% -134.50% -181.17% -124.14% -75.78%
Pre Tax Income Margin		 -1,806.51% -299.61% -327.95% -477.14% -263.30% -190.22% -254.42% -189.07% -261.62% -176.49% -109.55%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -0.39 -90.40 -42.96 -19.19 -15.63 -603.81 -1,017.63 -124.83 -70.57 -58.67 -66.26
NOPAT to Interest Expense		 -0.34 -65.51 -26.58 -10.69 -10.95 -428.83 -718.18 -89.51 -49.56 -41.97 -46.53
EBIT Less CapEx to Interest Expense		 -0.39 -91.32 -43.26 -19.25 -15.67 -603.81 -1,025.68 -125.37 -70.57 -58.87 -66.26
NOPAT Less CapEx to Interest Expense		 -0.34 -66.43 -26.89 -10.75 -10.99 -428.83 -726.23 -90.05 -49.56 -42.17 -46.53
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

NeurAxis (NASDAQ: NRXS) is still a pre-profit, cash-burning company, but Q1 2026 showed a much stronger balance sheet than a year ago, thanks largely to new equity financing. Revenue rose sharply year over year, but operating expenses also climbed, so losses remain substantial. The company ended the quarter with a large cash cushion relative to its recent history, which gives it more runway, though dilution remains a major overhang for shareholders.

  • Revenue growth accelerated in Q1 2026. Revenue increased to $1.61 million from $895.7 thousand in Q1 2025, a strong year-over-year gain.
  • Gross profit improved in both dollars and margin. Gross profit was $1.39 million, with gross margin around 86%, compared with roughly 84% in Q1 2025.
  • Cash balance improved materially. NeurAxis ended Q1 2026 with $7.08 million in cash and equivalents, up from $4.38 million at the end of Q3 2025 and well above the $2.00 million it had at Q1 2025.
  • Financing strengthened liquidity. The company generated $3.34 million of net cash from financing activities in Q1 2026, driven mainly by $2.99 million of common stock issuance.
  • Debt was reduced modestly. The company repaid $57.6 thousand of debt in Q1 2026.
  • Operating cash burn improved sequentially, but remained negative. Operating cash flow was negative $1.23 million in Q1 2026 versus negative $1.93 million in Q4 2025.
  • Quarterly net loss was similar to recent periods. Net loss was $1.76 million in Q1 2026, compared with $1.71 million in Q4 2025 and $1.69 million in Q2 2025.
  • Share count remains elevated versus earlier periods. Weighted average basic shares were 10.95 million in Q1 2026, up from 9.08 million in Q4 2025 and far above 6.52 million in Q1 2024.
  • Operating expenses remain far above revenue. SG&A alone was $3.03 million in Q1 2026, and total operating expenses of $3.13 million exceeded revenue by a wide margin.
  • Losses continue to outpace gross profit. Despite higher sales, the company posted an operating loss of $1.74 million and a pre-tax loss of $1.76 million in Q1 2026.

Longer-term trend: NeurAxis has made progress on top-line growth since 2024, but profitability has not improved enough to offset a still-heavy expense structure. Revenue has generally trended upward, yet quarterly losses have remained in the $1.5 million to $2.3 million range, and cash flow from operations has stayed negative across the period reviewed.

Balance sheet take: At March 31, 2026, total assets were $8.75 million against $3.00 million of liabilities, which is a much healthier position than some earlier quarters. That said, the improvement was aided by equity financing, so investors should weigh the stronger liquidity against ongoing dilution risk.

Bottom line: NRXS looks better capitalized than it did a year ago and is growing revenue, but it is still burning cash and not yet close to profitability. For retail investors, the key questions are whether revenue growth can continue at a faster pace and whether management can rein in expenses without stalling the business.

07/17/26 06:39 AM ETAI Generated. May Contain Errors.

NeurAxis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NeurAxis' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

NeurAxis' net income appears to be on an upward trend, with a most recent value of -$7.80 million in 2025, rising from -$4.78 million in 2022. The previous period was -$8.24 million in 2024. Check out NeurAxis' forecast to explore projected trends and price targets.

NeurAxis' total operating income in 2025 was -$7.83 million, based on the following breakdown:
  • Total Gross Profit: $3.01 million
  • Total Operating Expenses: $10.84 million

Over the last 3 years, NeurAxis' total revenue changed from $2.68 million in 2022 to $3.57 million in 2025, a change of 32.9%.

NeurAxis' total liabilities were at $3.00 million at the end of 2025, a 11.7% increase from 2024, and a 57.4% decrease since 2022.

In the past 3 years, NeurAxis' cash and equivalents has ranged from $78.56 thousand in 2023 to $4.97 million in 2025, and is currently $4.97 million as of their latest financial filing in 2025.

Over the last 3 years, NeurAxis' book value per share changed from -2.78 in 2022 to 0.32 in 2025, a change of -111.5%.


Related Companies

Financial statements for NASDAQ:NRXS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely, LLC | Sponsoredtc pixel